Bafna Pharmaceuticals Ltd, a globally successfull pharma company based In Chennai has emerged as one of the most competent player in the contract research and manufacturing industry, providing consistent and unmatched service to both domestic and international markets.
Bafna Pharmaceuticals is a EU - GMP, UK - MHRA, TGA Australia accredited facility in Betalactum and non-Betalactum solid oral dosage forms providing consistent and unmatched service by supplying hi-end pharmaceutical formulations to regulated markets of United Kingdom, Europe and Australia apart from emerging markets like Sri Lanka, Africa and CIS countries etc.
Currently it manufactures and market over 336 licensed pharmaceutical products across various therapeutic spectrums. It has a global presence with 80 of its products being registered and marketed across Asia, Africa, UK, Europe and Australia. Looking ahead, the company is strategically poised to enter into the arena of contract research & development on a large scale with its dedicated state-of-the-art the R&D centre in the regulated markets.
Bafna Pharmaceuticals forayed into the pharmaceutical manufacturing industry, way back in 1981. The consistent drive a of the CMD to expand their horizons resulted in the metamorphosis of Bafna Pharmaceuticals into a public limited company in 1995. Bafna has expanded its operations and set up new and improved manufacturing facilities in Chennai .More than two decades have passed since inception, yet its drive to innovate and exceed expectations remains unsurpassed.
Bafna Mahaveer Chand - Chairman and Managing Director has over three decades of experience in the pharmaceutical industry. A doyen in the industry with in-depth know-how and expertise of all aspects and operations of the industry. It was his vision which enabled the company to scale this height from a limited company in 1995, to the accreditation of Grantlyon facility with UK - MHRA and to the listing of the company in BSE during 2008.
His expertise enabled the company to bag several institutional supply contracts from the central government and several state Governments of India, the Contract Manufacturing deal from Croslands, Best Supplier Award from the Government of Sri Lanka, 336 product licenses, 80 product registrations globally and round the year export to prestigious regulated and emerging markets, contract manufacturing deal from Johnson and Johnson ltd, Gold Quality Excellence Award 2010, setting up the state–of–the-art R&D centre. Receiving the National Level Entrepreneurship Excellence Award in 2010 and UDYOG RATTAN AWARD 2011 are just a few landmarks of his successful sojourn at BAFNA.